Furthermore, it mediates chemoresistance through the ABC transporter G2 (ABCG2) in breast cancer, while, in hepatocellular carcinoma (HCC), it contributes to resistance via activation of the MAPK signaling pathways [16,17]. The gene discussed is ABCG2; the disease is hepatocellular carcinoma.